HomeCompareNGMS vs JNJ

NGMS vs JNJ: Dividend Comparison 2026

NGMS yields 6.79% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NGMS wins by $877.00 in total portfolio value
10 years
NGMS
NGMS
● Live price
6.79%
Share price
$29.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.3K
Annual income
$1,045.68
Full NGMS calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — NGMS vs JNJ

📍 NGMS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNGMSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NGMS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NGMS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NGMS
Annual income on $10K today (after 15% tax)
$577.25/yr
After 10yr DRIP, annual income (after tax)
$888.83/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $3,148.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NGMS + JNJ for your $10,000?

NGMS: 50%JNJ: 50%
100% JNJ50/50100% NGMS
Portfolio after 10yr
$30.9K
Annual income
$2,897.78/yr
Blended yield
9.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NGMS
Analyst Ratings
5
Hold
1
Sell
Consensus: Hold
Price Target
$29.50
+0.2% upside vs current
Range: $29.50 — $29.50
Altman Z
2.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NGMS buys
0
JNJ buys
0
No recent congressional trades found for NGMS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNGMSJNJ
Forward yield6.79%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$31.3K$30.5K
Annual income after 10y$1,045.68$4,749.88
Total dividends collected$8.7K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$29.50$228.73

Year-by-year: NGMS vs JNJ ($10,000, DRIP)

YearNGMS PortfolioNGMS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,379$679.12$10,594$274.49+$785.00NGMS
2$12,898$722.22$11,294$360.69+$1.6KNGMS
3$14,566$765.06$12,133$476.91+$2.4KNGMS
4$16,393$807.47$13,156$635.42+$3.2KNGMS
5$18,390$849.31$14,432$854.61+$4.0KNGMS
6$20,567$890.43$16,056$1,162.76+$4.5KNGMS
7$22,938$930.72$18,175$1,604.53+$4.8KNGMS
8$25,514$970.09$21,009$2,252.68+$4.5KNGMS
9$28,308$1,008.43$24,911$3,229.73+$3.4KNGMS
10$31,335$1,045.68$30,458$4,749.88+$877.00NGMS

NGMS vs JNJ: Complete Analysis 2026

NGMSStock

NeoGames S.A. provides iLottery solutions worldwide. The company offers various technology platforms, a range of value-added services, and a game studio that provides a portfolio of draw based games and instant tickets through personal computers, smartphones, and handheld devices. It also develops and operates online lotteries and games that allows lottery operators to distribute lottery products through online sales channels using the company's technology. In addition, the company offers software development and platforms sub-licensing services; and regulation and compliance, payment processing, risk management, player relationship management, and player value optimization services. The company was incorporated in 2014 and is headquartered in Tel Aviv, Israel.

Full NGMS Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this NGMS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NGMS vs SCHDNGMS vs JEPINGMS vs ONGMS vs KONGMS vs MAINNGMS vs ABBVNGMS vs MRKNGMS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.